Skip to main content
. 2018 Mar 1;3(1):21–34. doi: 10.1089/can.2017.0043

Table 4.

Psychological Functioning and Symptom Scores and Cognitive Performance at Baseline and Post-Treatment

  Baseline Post-treatment t/Za p Effect size d/ra
BDI 2.5 [0–14] 0.5 [0–12] 2.49 0.013 0.39
STAI-I 23.5 [20–38] 29.5 [20–49] −2.43 0.015 0.38
STAI-II 32 [20–63] 32 [20–49] 1.19 0.23 0.19
GAF 85 [70–95] 85 [60–95] 0.88 0.38 0.14
SOFAS 85 [65–95] 85 [55–95] 0.88 0.38 0.14
CAPE
 Frequency total 59.25 (10.22) 56.00 (8.97) 2.21 0.040 0.50
 Distress total 23.25 (16.49) 18.40 (12.50) 2.35 0.030 0.58
 Negative frequency 22.95 (4.49) 21.6 (4.78) 1.62 0.12 0.36
 Negative distress 11.80 (7.36) 9.95 (6.71) 1.71 0.10 0.39
 Positive frequency 24.60 (4.49) 23.00 (3.68) 2.65 0.016 0.62
 Positive distress 3 [0–20] 2 [0–15] 2.29 0.022 0.36
 Depressive frequency 11.70 (2.39) 11.40 (1.96) 0.56 0.58 0.13
 Depressive distress 5.80 (4.57) 4.95 (4.26) 0.96 0.35 0.22
RAVLT
 Words recalled Trials 1–5 52.55 (11.07) 56.00 (9.70) −2.25 0.038 0.53
 Recall postinterference 10.30 (3.29) 11.42 (2.95) −2.30 0.033 0.54
 Delayed recall 10.55 (3.35) 10.89 (3.25) −0.84 0.41 0.19
AST
 Overall latency correct 518.65 (62.68) 492.60 (36.81) 2.44 0.025 0.63
 Latency congruent 493.68 (56.96) 474.00 (38.68) 2.07 0.053 0.50
 Latency incongruent 552.28 (68.49) 513.40 (42.55) 3.53 0.002 0.90
 Latency switching trials 600.63 (86.21) 549.30 (53.40) 2.97 0.008 0.71
 Switching cost 152.20 (70.80) 115.38 (68.78) 2.38 0.028 0.53

Mean (SD) or median [range].

a

Paired samples t-test for normally distributed data; Wilcoxon signed-rank test for skewed data.